Bleomycin-detectable Iron Assay for Non-Transferrin-bound Iron in Hematologic Malignancies
Open Access
- 1 February 2002
- journal article
- clinical trial
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 48 (2) , 307-314
Abstract
Background: A microwell modification of the bleomycin assay for determining non-transferrin-bound iron (NTBI) was evaluated and compared with a chelation method. Methods: The bleomycin assay reagent and sample volumes were halved, and measurements were done in microwell plates. Samples from patients treated for hematologic malignancies were studied. The chelation method was based on mobilization of NTBI with a chelator and measurement of the ultrafiltered iron-chelator complex. NTBI results were also compared with transferrin saturation and the distribution of transferrin iron forms by urea-polyacrylamide gel electrophoresis. Results: The bleomycin assay intraassay imprecision (CV) was 7.7% and 8.2% and the interassay imprecision was 18% and 9.8% for a low (0.2 μmol/L) and a high (1.5 μmol/L) control, respectively. Hemolysis increased measured NTBI. A detection limit of 0.1 μmol/L was established based on the interference of nonvisible hemolysis and on accuracy studies. In patient samples, NTBI exceeded the detection limits only when transferrin saturation was >80%. Compared with the chelation method, the bleomycin assay gave clearly lower NTBI concentrations. The chelation method also gave positive results at 80%, suggesting high specificity. Bleomycin-detectable iron constitutes only a portion of the NTBI measured by the chelation method.Keywords
This publication has 26 references indexed in Scilit:
- MiscellaneousJournal of Gastroenterology and Hepatology, 1999
- Quantification of Non-Transferrin-Bound Iron in the Presence of Unsaturated TransferrinAnalytical Biochemistry, 1999
- Blood cardioplegia increases plasma iron overload and thiol levels during cardiopulmonary bypassThe Annals of Thoracic Surgery, 1995
- Presence of iron catalytic for free radical reactions in patients undergoing chemotherapy: implications for therapeutic managementCancer Letters, 1995
- Non-transferrin bound iron and neutropenia after cytotoxic chemotherapy.Journal of Clinical Pathology, 1994
- Bleomycin‐detectable iron in the plasma of premature and full‐term neonatesFEBS Letters, 1992
- A direct method for quantification of non-transferrin-bound ironAnalytical Biochemistry, 1990
- [1] Role of free radicals and catalytic metal ions in human disease: An overview1990
- Bleomycin‐detectable iron in serum from leukaemic patients before and after chemotherapy Therapeutic implications for treatment with oxidant‐generating drugsFEBS Letters, 1988
- Non‐Specific Serum Iron in Thalassaemia: an Abnormal Serum Iron Fraction of Potential ToxicityBritish Journal of Haematology, 1978